Embolic stroke of unknown source (ESUS) represents one in five ischemic strokes.
Ipsilateral non-stenotic carotid plaques are identified in 40% of all ESUS. In this narrative …

Intensive antiplatelet therapy did not reduce recurrent stroke/transient ischaemic attack (TIA)
events as compared with guideline treatment in the Triple Antiplatelets for Reducing …

Stroke was one of the most frequent diseases with significant disability and mortality.[1]
Several studies confirmed that intravenous thrombolysis with alteplase can effectively …

Objectives: 1. To explore the incidence of concurrent gouty arthritis (GA) during
hospitalization in patients with different subtypes of acute stroke. 2. To investigate disparities …

目的探讨短暂性脑缺血发作(transient ischemic attack, TIA) 患者出院后二级预防用药情况及其
影响因素, 并通过质性研究探讨患者服药的动机和障碍. 方法选取2016 年1 月至2020 年12 …

[目的] 探讨恩必普软胶囊治疗短暂性脑缺血发作(TIA) 患者的疗效及对相关因子的影响.[方法]
110 例TIA 患者随机分为观察组和对照组, 每组55 例. 在给予常规治疗的基础上 …

[目的] 比较达比加群酯, 利伐沙班及华法林治疗房颤的疗效及安全性.[方法] 前瞻性选取2020 年1
月至2022 年1 月陕西省山阳县人民医院收治的243 例房颤患者, 根据随机数字表法将其分为A …

Antiplatelet agents have been utilized to enhance outcomes in patients with acute coronary
syndrome for decades and are increasingly valued for their antithrombotic as well as anti …

Carotid atherosclerosis is responsible for 15-25% of the nearly 8 million first-ever ischemic
strokes that occur each year worldwide. This proportion has remained constant over the past …

Background/Purpose Antiplatelet therapy is the cornerstone for acute ischemic stroke or
transient ischemic attack (TIA). The purpose of this study was to conduct a meta-analysis to …